The National Institute for Health Research (NIHR) offers, through its Office of Clinical Research Infrastructures, a series of model research partnership agreements with the pharmaceutical and biotechnology industry, universities and NHS organisations. The Intellectual Property Office collaborated with NIHR and the Medical Research Council to develop the Industry Collaborative Research Agreement (MICRA) model. Negotiating agreements on the ownership and management of intellectual property, which is generated through collaborative research partnerships, is critical to the success of the relationship. Model agreements can, in cooperation, help the parties to determine in a fair and equitable manner the ownership of any intellectual property generated in the course of a joint project. We support the use of model agreements such as the Lambert Toolbox, developed by universities, UK businesses and professional organisations, as a good starting point for negotiations. Some of the findings from the authors of the recent review (including IP Pragmatics CEO Dr. Rupert Osborn) argue that while it is still too early to assess the real impact of the updated toolkit, model 1-1 agreements seem more popular than multi-stakeholder consortium agreements and that guidelines and the decision tree are widely hailed as useful tools. We worked with British and Chinese experts to create a new toolbox. The aim is to help non-IP experts deal with issues related to the ownership and exploitation of IP rights generated by cooperation between Britain and China. The toolkit includes guides and nine model agreements.
Consortium agreements B and C have been designed for use with Innovate UK`s collaborative R&D programme. With a few modifications, they can be adapted for other circumstances. These facilitate contract negotiations with publicly funded research organisations (e.g. B universities) and enterprises. Initially launched in 2005, it consists of 5 model individual cooperation agreements and 4 multi-party consortium agreements. Public Health England has established a standard fast track agreement (MS Word Document, 62.4KB) to very quickly assess possible treatment options for Ebola and Zika and share the results with stakeholders for a coordinated global response. Following consultations, it is now available in the form of a model agreement that can be adapted to any crisis affecting human, animal and/or environmental health. There are two modelling agreements, one for bipartite cooperation agreements and the other for multi-party consortium agreements. These agreements can be used if a new party joins the project. . .